GlassScriptPhysician profile
Holly Blankenship
NPI 1720793888
$1,506.31
in general payments reported to CMS, 2019-2025
15 companies · $631 in 2025
The $631 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $250 · 2024: $626 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,506.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $422.59 | 2023-2025 | Puraply, Cygnus Matrix, Cygnus Dual |
| Bayer Healthcare Pharmaceuticals INC. | $360.78 | 2023-2025 | |
| Lilly USA, LLC | $311.73 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $84.14 | 2024-2025 | Gvoke Hypopen |
| Insulet Corporation | $50.72 | 2024-2025 | Omnipod |
| Smith+Nephew, INC. | $49.55 | 2024-2025 | Renasys Touch, Grafix Pl, Oasis |
| Astrazeneca Pharmaceuticals LP | $36.50 | 2023-2024 | Farxiga |
| Solventum Corporation | $33.55 | 2024-2025 | Activ.A.C. |
| Tandem Diabetes Care, INC. | $32.74 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Advanced Oxygen Therapy INC. | $31.00 | 2025 | Topical Oxygen Chamber For Extremities |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.62 | 2025 | Jardiance |
| Esperion Therapeutics, INC. | $20.16 | 2025 | Nexletol |
| Kerecis Limited | $17.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Reprise Biomedical, INC. | $14.18 | 2025 | Miro3d |
| Hartmann USA, INC. | $13.88 | 2024 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Blankenship listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.